vs

Side-by-side financial comparison of Solo Brands, Inc. (SBDS) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $94.0M, roughly 1.5× Solo Brands, Inc.). Oncology Institute, Inc. runs the higher net margin — -5.3% vs -88.4%, a 83.2% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs -34.5%). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 5.0%).

Conagra Brands, Inc. is an American consumer packaged goods holding company that makes and sells products under various brand names that are available in supermarkets, restaurants, and food service establishments. Based on its 2021 revenue, the company ranked 331st on the 2022 Fortune 500. Headquartered in Chicago, Illinois, Conagra was founded in Nebraska in 1919 and was originally called Nebraska Consolidated Mills.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

SBDS vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
1.5× larger
TOI
$142.0M
$94.0M
SBDS
Growing faster (revenue YoY)
TOI
TOI
+76.1% gap
TOI
41.6%
-34.5%
SBDS
Higher net margin
TOI
TOI
83.2% more per $
TOI
-5.3%
-88.4%
SBDS
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
5.0%
SBDS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SBDS
SBDS
TOI
TOI
Revenue
$94.0M
$142.0M
Net Profit
$-83.2M
$-7.5M
Gross Margin
60.6%
Operating Margin
-81.7%
-4.9%
Net Margin
-88.4%
-5.3%
Revenue YoY
-34.5%
41.6%
Net Profit YoY
-42.9%
43.0%
EPS (diluted)
$-45.73
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SBDS
SBDS
TOI
TOI
Q4 25
$94.0M
$142.0M
Q3 25
$53.0M
$136.6M
Q2 25
$92.3M
$119.8M
Q1 25
$77.3M
$104.4M
Q4 24
$143.5M
$100.3M
Q3 24
$94.1M
$99.9M
Q2 24
$131.6M
$98.6M
Q1 24
$85.3M
$94.7M
Net Profit
SBDS
SBDS
TOI
TOI
Q4 25
$-83.2M
$-7.5M
Q3 25
$-22.9M
$-16.5M
Q2 25
$-20.8M
$-17.0M
Q1 25
$-18.6M
$-19.6M
Q4 24
$-58.2M
$-13.2M
Q3 24
$-111.5M
$-16.1M
Q2 24
$-4.0M
$-15.5M
Q1 24
$-6.5M
$-19.9M
Gross Margin
SBDS
SBDS
TOI
TOI
Q4 25
60.6%
Q3 25
60.0%
Q2 25
61.3%
Q1 25
55.2%
Q4 24
61.1%
Q3 24
41.8%
Q2 24
62.8%
Q1 24
59.2%
Operating Margin
SBDS
SBDS
TOI
TOI
Q4 25
-81.7%
-4.9%
Q3 25
-30.5%
-5.9%
Q2 25
-10.7%
-9.4%
Q1 25
-13.8%
-9.5%
Q4 24
-38.5%
-11.9%
Q3 24
-122.5%
-13.9%
Q2 24
1.7%
-16.6%
Q1 24
-7.4%
-19.0%
Net Margin
SBDS
SBDS
TOI
TOI
Q4 25
-88.4%
-5.3%
Q3 25
-43.2%
-12.1%
Q2 25
-22.5%
-14.2%
Q1 25
-24.0%
-18.8%
Q4 24
-40.6%
-13.1%
Q3 24
-118.4%
-16.1%
Q2 24
-3.1%
-15.7%
Q1 24
-7.6%
-21.0%
EPS (diluted)
SBDS
SBDS
TOI
TOI
Q4 25
$-45.73
$-0.04
Q3 25
$-9.22
$-0.14
Q2 25
$-8.93
$-0.15
Q1 25
$-0.21
$-0.21
Q4 24
$-27.74
$-0.14
Q3 24
$-47.72
$-0.18
Q2 24
$-2.14
$-0.17
Q1 24
$-0.06
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SBDS
SBDS
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$20.0M
Total DebtLower is stronger
$242.1M
Stockholders' EquityBook value
$46.0M
$-15.7M
Total Assets
$360.3M
$164.7M
Debt / EquityLower = less leverage
5.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SBDS
SBDS
TOI
TOI
Q4 25
$20.0M
Q3 25
$16.3M
Q2 25
$18.1M
Q1 25
$206.4M
Q4 24
$12.0M
Q3 24
$12.5M
Q2 24
$20.1M
$9.9M
Q1 24
$15.4M
$29.8M
Total Debt
SBDS
SBDS
TOI
TOI
Q4 25
$242.1M
Q3 25
$235.2M
Q2 25
$238.4M
Q1 25
$427.9M
Q4 24
$150.7M
Q3 24
$161.1M
Q2 24
$162.2M
Q1 24
$170.2M
Stockholders' Equity
SBDS
SBDS
TOI
TOI
Q4 25
$46.0M
$-15.7M
Q3 25
$99.1M
$-12.3M
Q2 25
$113.2M
$-9.0M
Q1 25
$121.7M
$5.1M
Q4 24
$133.7M
$3.6M
Q3 24
$168.0M
$15.5M
Q2 24
$236.7M
$29.2M
Q1 24
$238.5M
$41.3M
Total Assets
SBDS
SBDS
TOI
TOI
Q4 25
$360.3M
$164.7M
Q3 25
$431.0M
$163.6M
Q2 25
$459.7M
$159.8M
Q1 25
$692.4M
$164.0M
Q4 24
$495.1M
$172.7M
Q3 24
$553.2M
$179.2M
Q2 24
$642.0M
$179.6M
Q1 24
$648.3M
$204.5M
Debt / Equity
SBDS
SBDS
TOI
TOI
Q4 25
5.26×
Q3 25
2.37×
Q2 25
2.11×
Q1 25
3.52×
Q4 24
1.13×
Q3 24
0.96×
Q2 24
0.69×
Q1 24
0.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SBDS
SBDS
TOI
TOI
Operating Cash FlowLast quarter
$6.4M
$3.2M
Free Cash FlowOCF − Capex
$2.2M
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SBDS
SBDS
TOI
TOI
Q4 25
$6.4M
$3.2M
Q3 25
$11.2M
$-12.6M
Q2 25
$10.9M
$-10.2M
Q1 25
$-75.2M
$-5.0M
Q4 24
$13.0M
$4.2M
Q3 24
$378.0K
$819.0K
Q2 24
$15.7M
$-15.7M
Q1 24
$-18.5M
$-15.9M
Free Cash Flow
SBDS
SBDS
TOI
TOI
Q4 25
$2.2M
Q3 25
$-13.2M
Q2 25
$-11.4M
Q1 25
$-78.4M
$-5.3M
Q4 24
$9.0M
$2.4M
Q3 24
$-5.9M
$417.0K
Q2 24
$12.8M
$-17.5M
Q1 24
$-20.9M
$-16.5M
FCF Margin
SBDS
SBDS
TOI
TOI
Q4 25
1.5%
Q3 25
-9.7%
Q2 25
-9.5%
Q1 25
-101.5%
-5.1%
Q4 24
6.3%
2.4%
Q3 24
-6.3%
0.4%
Q2 24
9.8%
-17.7%
Q1 24
-24.5%
-17.4%
Capex Intensity
SBDS
SBDS
TOI
TOI
Q4 25
0.7%
Q3 25
0.4%
Q2 25
1.0%
Q1 25
4.2%
0.3%
Q4 24
2.8%
1.8%
Q3 24
6.7%
0.4%
Q2 24
2.2%
1.9%
Q1 24
2.8%
0.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SBDS
SBDS

Sales Channel Directly To Consumer$65.4M70%
Sales Channel Through Intermediary$28.6M30%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons